{"id":21324,"date":"2013-05-29T14:22:07","date_gmt":"2013-05-29T14:22:07","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=21324"},"modified":"2013-05-29T14:22:07","modified_gmt":"2013-05-29T14:22:07","slug":"plos-medicine%e2%80%a8-free-full-text-online-articles","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/21324","title":{"rendered":"PLoS Medicine\u2028: free full text online articles"},"content":{"rendered":"<p><strong>Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies<br \/>\n<\/strong>Johnson LF et al.<br \/>\n<a href=\"http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001418#abstract2\">http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001418#abstract2<\/a><br \/>\nThis study estimates 80% of normal life expectancy for HIV positive South African adults who start ARVS while their CD4 count is still 200 or higher by using information from 6 programmes between 2001 and 2010.<\/p>\n<p><strong>The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies<\/strong><br \/>\nGomez GB et al.<br \/>\n<a href=\"http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001401\">http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001401<\/a><\/p>\n<p><strong>Preventing antiretroviral treatment interruptions among HIV\/AIDS patients in Africa<\/strong><br \/>\nMills EJ and Nabiryo C.<br \/>\n<a href=\"http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001370\">http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001370<\/a><br \/>\nNorma Ware and colleagues conducted a large qualitative study among patients in HIV treatment programs in sub-Saharan Africa to investigate reasons for missed visits and provide an explanation for disengagement from care.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies Johnson LF et al. http:\/\/www.plosmedicine.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pmed.1001418#abstract2 This study estimates 80% of normal life expectancy for HIV positive South African adults who start ARVS while their CD4 count &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-21324","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=21324"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21324\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=21324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=21324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=21324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}